• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

A study of multi-functional HGF in Urologic field

Research Project

Project/Area Number 08407053
Research Category

Grant-in-Aid for Scientific Research (A)

Allocation TypeSingle-year Grants
Section一般
Research Field Urology
Research InstitutionOsaka University

Principal Investigator

OKUYAMA Akihiko  Osaka University Medical School, Professor, 医学部, 教授 (20093388)

Co-Investigator(Kenkyū-buntansha) KITAMURA Masaya  Osaka University Medical School, Assistant Professor, 医学部, 助手 (70273688)
MATSUMIYA Kiyomi  Osaka University Medical School, Lecturer, 医学部, 講師 (90243237)
TAKAHARA Shiro  Osaka University Medical School, Lecturer, 医学部, 講師 (70179547)
Project Period (FY) 1996 – 1997
Project Status Completed (Fiscal Year 1997)
Budget Amount *help
¥16,100,000 (Direct Cost: ¥16,100,000)
Fiscal Year 1997: ¥7,900,000 (Direct Cost: ¥7,900,000)
Fiscal Year 1996: ¥8,200,000 (Direct Cost: ¥8,200,000)
KeywordsHGF / Cytokine / Renal transplantation / Prostatic cancer / 慢性拒絶反応 / ラットモデル / マトリゲル / 腎虚血
Research Abstract

HGF has been a focus of many researches as a multifunctional cytokine. We attained completely satisfactory results in 1997 and 1998, leading the world's researches of HGF concerning the following organs.
1. Kidney
Firstly, we showed the increased level of HGF during clinical rejection (Transpl Int), and proved preventive effect against renal toxicity of immunosuppressant. (Transpl Pro). Trying to see its long-term effect, we injected HGF intravenously for 4 weeks after renal transplantation in the rats. Surprisingly, 46% rats in the control group lost the function of the graft after 8 months, while in HGF group, all grafts survived functionally. Now we don't have any therapy for chronic rejection in renal transplantation. This study might give us a clue for using a cytokine to treat it.
2. Prostatic cancer cell lines
We studied the effects of HGF to invasive potential of three prostatic cancer cell lines. Two of them had c-MET,HGF receptor and only DU145 had responsiveness to HGF (Int J Urol). Furthermore, culture sup of fibroblast also could induce invasive potential of DU145 and it was inhibited by antibodies to HGF.Prostatic cancer is well known for a unique stromal-epitherial interaction and on-going experiments using different stromal cells might give us a clue to its understanding.
3. Male reproductive organs
We tried immunohistochemical study of HGF but the details remained unclear probably due to the level of expression.

Report

(3 results)
  • 1997 Annual Research Report   Final Research Report Summary
  • 1996 Annual Research Report
  • Research Products

    (17 results)

All Other

All Publications (17 results)

  • [Publications] Shingo Takada: "HGF provents facrolimus(Fk506)-induced nephotoxicity in SHR rats." Transplantation Proceedings. 28・2. 1089-1090 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Shingo Takada: "Serum HGF levels in acute reval rejection after living related reval transplantation" Transplantation International. 9. 151-154 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Haruhito Azuma: "HGF prevented the changes of chronic rejection on rat model of lciduey allografts" the Journal of Urology. 157. 273- (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Kenji Nishimura: "Regulation of hypotocyte growth factor/scatter factor(HGF/SF)in human prostate cancer cell lines" the Journal of Urology. 157. 20- (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] 西山 憲二: "リコンビナントhHGFによるタクロリムス腎毒性の予防" 今日の移植. 10・2. 265-269 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Kenji Nishimura: "Regulation of invasive potential of human prostate cancer cell lines by hepatocyte growth factor." International Journal of Urology. (in press).

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Takada S., Namiki M., Takahara S., Matsumiya K., Kondoh N., Kitamura M., Uchida K., Koga M., Jiang H., Kokado Y., Kameoka H., Miki T., Matsumoto K., Nakamura T.and Okuyama A.: "HGF prevents tacrolimus (FK506) -induced nephrotoxicity in SHR rats." Transpl Proceed. 28 (2). 1089-1090 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Takada S., Namiki M., Takahara S., Matsumiya K., Kondoh N., Kokado Y., Matsumoto K., Nakamura T.and Okuyama A.: "Serum HGF levels in acute renal rejection after living related renal transplantation." Transpl Int. 9. 151-154 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Nishimura K., Matsumiya K., Takada S., Kitamura M., Uchida K., Matsumoto K., Nakamura T.and Okuyama A.: "Regulation of hepatocyte growth factor/scatter factor (HGF/SF) in human prostate cancer cell lines." J Urol. 157. 20 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Nishimura K., Matsumiya K., Takada S., Kitamura M., Kokado Y., Takahara S., Matsumoto K., Nakamura T.and Okuyama A.: "Hepatocyte growth factor (HGF) prevents the tacrolimus (FK506) induced nephrotoxicity in spontaneous hypertensive rats." Transplantation Now. 10 (2). 265-269 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Nishimura K., Kitamura M., Takada S., Nonomura N., Matsumiya K., Miki T., Matsumoto K., and Okuyama A.: "Regulation of invasive potential of human prostate cancer cell lines by hepatocyte growth factor" Int J Urol. (in press.).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1997 Final Research Report Summary
  • [Publications] Shingo Takada: "HGF prevents tacrolimus (FK506)-induced uephrotoxicity in SHR rats." Transolantation Procedings. 28・2. 1089-1090 (1996)

    • Related Report
      1997 Annual Research Report
  • [Publications] Shingo Takada: "Serum HGF levels in acute renal rojection after living related reval transplantation" Tronsolantation International. 9. 151-154 (1996)

    • Related Report
      1997 Annual Research Report
  • [Publications] Haruhito Azuma: "HGF prevented the changes of chronic rejection on rat model of kiduey allografts" The Journal of Urology. 157・4. 273 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Kenji Nishimura: "Regulation of hepatocyte growth factor/scatter factor (HGF/SF) in human prostate cancer cell lines" The Journal of Orology. 157・4. 20 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] 西村 憲二: "リコンビナントhHGFによるタクロリムス腎毒性の予防" 今日の移植. 10・2. 265-269 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Kenji Nishimura: "Regulation of invasive potential of human prostate cancer cell lines by hepatocyte growth factor" International Journal of Urology. (in press).

    • Related Report
      1997 Annual Research Report

URL: 

Published: 1996-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi